BRIEF published on 09/29/2025 at 18:05, 6 months 17 days ago BIOSYNEX initiates financial restructuring and will liquidate its subsidiary AVALUN Financial Restructuring BIOSYNEX AVALUN Backup Procedure Compulsory Liquidation
BRIEF published on 09/25/2025 at 18:05, 6 months 21 days ago BIOSYNEX begins safeguard proceedings, AVALUN ceases payment Debt BIOSYNEX AVALUN Backup Procedure Cessation Of Payment
BRIEF published on 07/29/2025 at 18:50, 8 months 18 days ago Biosynex Achieves Breakthrough Device Status for Its Syphilis Test FDA Syphilis Breakthrough Device Rapid Diagnosis Chembio
BRIEF published on 07/17/2025 at 18:05, 8 months 30 days ago BIOSYNEX announces a decline in revenue for the first half of 2025 Restructuring Product Launches Turnover BIOSYNEX First Half Of 2025
BRIEF published on 05/06/2025 at 15:15, 11 months 10 days ago BIOSYNEX: Number of Shares and Voting Rights as of February 28, 2025 Share Capital Voting Rights Euronext Growth BIOSYNEX Health Diagnosis
BRIEF published on 04/23/2025 at 18:05, 11 months 23 days ago BIOSYNEX SA: 2024 Results and 2025 Reorganization Plan Financial Structure BIOSYNEX SA 2024 Results Export Growth Reorganization 2025
BRIEF published on 03/04/2025 at 18:05, 1 year 1 month ago BIOSYNEX: Declaration of the number of shares and voting rights Share Capital Voting Rights Actions BIOSYNEX Health Diagnosis
BRIEF published on 02/12/2025 at 08:05, 1 year 2 months ago BIOSYNEX successfully completes its capital increase Capital Increase Subscription BIOSYNEX Dilution Of Shareholders Oversubscription Rate
BRIEF published on 01/22/2025 at 07:05, 1 year 2 months ago Launch of the capital increase by BIOSYNEX SA Shareholders Capital Increase Subscription BIOSYNEX Preferential Subscription Right
BRIEF published on 01/13/2025 at 18:20, 1 year 3 months ago Growth and Restructuring: Biosynex in 2024 Restructuring Economic Growth Export Sales Pharmacy Division Diagnostic Division
Published on 04/17/2026 at 02:13, 2 hours 21 minutes ago CHAR Tech annonce l’acquisition projetée d’actifs de biocarbone au Québec, incluant un accord d’achat de 62 500 tonnes, une installation et de la propriété intellectuelle
Published on 04/17/2026 at 02:00, 2 hours 34 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 5 hours 2 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 7 hours 4 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 23:40, 4 hours 54 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 6 hours 57 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 7 hours 34 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 7 hours 59 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 9 hours 16 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 10 hours 32 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 10 hours 40 minutes ago Aéroports de Paris S.A - March 2026 traffic figures
